Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab

医学 内科学 曲妥珠单抗 免疫组织化学 肿瘤科 队列 胃肠病学 癌症 外科肿瘤学 乳腺癌
作者
Kyunghye Bang,Jaekyung Cheon,Young Soo Park,Hyung‐Don Kim,Min‐Hee Ryu,Yangsoon Park,Meesun Moon,Hyungeun Lee,Yoon‐Koo Kang
出处
期刊:Gastric Cancer [Springer Nature]
卷期号:25 (4): 794-803 被引量:17
标识
DOI:10.1007/s10120-022-01298-6
摘要

The GASTHER1 study showed that re-evaluation of HER2 status rescued 8% of HER2-positive gastric cancer (GC) patients with initially HER2-negative GC. Since rescued HER2 positivity represents HER2 heterogeneity, we aimed to investigate this in a larger cohort with longer follow-up duration.Data of 153 HER2-positive advanced GC patients who received first-line trastuzumab-based chemotherapy were analyzed. Repeat endoscopic biopsy was performed in patients with initially HER2-negative GC. Survival outcomes were analyzed according to the immunohistochemistry (IHC) score (IHC 2+ /in situ hybridization [ISH] + vs IHC 3+), HER2 status (initially vs rescued HER2 positive), and H-score.IHC 2+ /ISH + patients showed worse progression-free survival (PFS) and overall survival (OS) than those with IHC 3+ (p < 0.05). Rescued HER2-positive patients showed worse PFS and OS than initially HER2-positive patients (p < 0.05). Although survival outcomes were comparable according to HER2 status in IHC 2+ /ISH + patients, initially HER2-positive patients showed more favorable PFS and OS than rescued HER2-positive patients (p < 0.05) among those with IHC 3+ . Among the subgroups determined by HER2 status and IHC score, the initially IHC 3+ subgroup had the highest H-score. The low H-score group (H-score ≤ 210) had significantly worse survival outcomes than the high H-score group (H-score > 210) (p < 0.05). An H-score of ≤ 210 was independently associated with shorter OS (HR = 1.54, 95% CI 1.02-2.31, p = 0.04).Rescued HER2-positive patients showed worse clinical outcomes than initially HER2-positive patients, especially those with IHC 3+ . This finding highlights the impact of HER2 heterogeneity, which can be quantified indirectly as an H-score.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
吉祥应助zjujirenjie采纳,获得30
刚刚
自然友菱完成签到,获得积分10
1秒前
桐桐应助义气的莛采纳,获得10
1秒前
2秒前
gnr2000应助科研通管家采纳,获得10
3秒前
CodeCraft应助科研通管家采纳,获得10
3秒前
不配.应助科研通管家采纳,获得10
3秒前
打打应助科研通管家采纳,获得10
3秒前
3秒前
不配.应助科研通管家采纳,获得10
3秒前
搜集达人应助科研通管家采纳,获得10
4秒前
NexusExplorer应助科研通管家采纳,获得10
4秒前
FashionBoy应助科研通管家采纳,获得10
4秒前
香蕉觅云应助科研通管家采纳,获得10
4秒前
搜集达人应助科研通管家采纳,获得10
4秒前
深情安青应助科研通管家采纳,获得10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
岚12发布了新的文献求助10
6秒前
6秒前
思源应助机灵盼芙采纳,获得10
8秒前
精明的曲奇完成签到,获得积分10
10秒前
14秒前
寡核苷酸小白完成签到 ,获得积分10
17秒前
JackMa应助huang采纳,获得10
18秒前
deepast发布了新的文献求助10
20秒前
20秒前
goodluck应助SCINEXUS采纳,获得10
20秒前
鲁滨逊完成签到 ,获得积分10
21秒前
shirley要奋斗完成签到 ,获得积分10
22秒前
水若琳完成签到,获得积分10
22秒前
27秒前
frenchfriespie完成签到,获得积分10
27秒前
27秒前
一行发布了新的文献求助10
27秒前
28秒前
31秒前
31秒前
33秒前
34秒前
ferritin完成签到 ,获得积分10
34秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
Evolution 3rd edition 1500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3187770
求助须知:如何正确求助?哪些是违规求助? 2837517
关于积分的说明 8015287
捐赠科研通 2500112
什么是DOI,文献DOI怎么找? 1334764
科研通“疑难数据库(出版商)”最低求助积分说明 637295
邀请新用户注册赠送积分活动 605251